| Literature DB >> 35052753 |
Mina Aleemardani1, Pariya Zare2, Amelia Seifalian3, Zohreh Bagher4, Alexander M Seifalian5.
Abstract
Peripheral nerve injury is a common medical condition that has a great impact on patient quality of life. Currently, surgical management is considered to be a gold standard first-line treatment; however, is often not successful and requires further surgical procedures. Commercially available FDA- and CE-approved decellularized nerve conduits offer considerable benefits to patients suffering from a completely transected nerve but they fail to support neural regeneration in gaps > 30 mm. To address this unmet clinical need, current research is focused on biomaterial-based therapies to regenerate dysfunctional neural tissues, specifically damaged peripheral nerve, and spinal cord. Recently, attention has been paid to the capability of graphene-based materials (GBMs) to develop bifunctional scaffolds for promoting nerve regeneration, often via supporting enhanced neural differentiation. The unique features of GBMs have been applied to fabricate an electroactive conductive surface in order to direct stem cells and improve neural proliferation and differentiation. The use of GBMs for nerve tissue engineering (NTE) is considered an emerging technology bringing hope to peripheral nerve injury repair, with some products already in preclinical stages. This review assesses the last six years of research in the field of GBMs application in NTE, focusing on the fabrication and effects of GBMs for neurogenesis in various scaffold forms, including electrospun fibres, films, hydrogels, foams, 3D printing, and bioprinting.Entities:
Keywords: biomedicine; drug delivery; functionalized graphene oxide; graphene-based materials; nerve differentiation; nerve proliferation; nerve tissue engineering; nervous system; plastic surgery; regenerative medicine; spinal cord injury; surgery
Year: 2021 PMID: 35052753 PMCID: PMC8773001 DOI: 10.3390/biomedicines10010073
Source DB: PubMed Journal: Biomedicines ISSN: 2227-9059
Figure 1Introduction of nervous system. (Illustrated by authors and utilising a real image of damaged myelin [33]).
Figure 2Due to the damage, the axons and myelin are fragmented at the injury site. Dedifferentiation and proliferation of mature myelinating Schwann cells occur. Then, after dedifferentiation, myelin and axonal debris are removed by Schwann cells or by recruiting circulating macrophages and producing neurotrophic factors that support axon regeneration. Schwann cells downregulate myelin-associated genes, which are vital for myelinations such as Krox20/Egr-235, and re-express molecules correlated with immature states such as the p75 neurotrophin receptor (p75NTR) and the neural cell adhesion molecule (NCAM). Reused with permission [10].
Figure 3Schematic of graphene (G), graphene oxide (GO), reduced graphene oxide (rGO) and functionalized graphene (FGO) materials in nerve tissue engineering, both in vitro and in vivo, in various forms of scaffolds, such as film, electrospun mat, foam or sponge, hydrogel, 3D print, and conduit.
Tissue-engineered 3D scaffolds containing graphene-based materials with for nerve regeneration. Keywords: ApF, A.pernyi silk; BM-MSCs, bone marrow-derived mesenchymal stem cells; CNS, central nervous system; CNTpega, Carbon nanotube poly-(ethylene glycol) acrylate; CPM, cell proliferation and migration; MP, mechanical properties; MTAC, 2-(methacryloyloxy)ethyltrimethylammonium chloride; NGF, nerve growth factor; NR, nerve regeneration; NSCs, neural stem cells; OPF, oligo(poly(ethylene glycol) fumarate; PCL, polycaprolactone; PEG, polyethylene glycol; PEI, polyethylenimine; PLGA, poly(lactic-co-glycolic acid); PLLA, polypyrrole-poly-l-lactic acid; PNS, peripheral nerve system; PVA, polyvinyl alchol; RGCs, retinal ganglion cells; SCI, spinal cord injury; =>, result in; +, by addition; ↑, higher or increase; ↓↓ minimize; * tested in preclinical rat model.
| Biomaterial(s) | GBMs | Target | Outcomes | Year | |
|---|---|---|---|---|---|
|
| Silk/rGO and SF/rGO | 5% and 10% | PNS | Conductivity: 4 × 10−5 S/cm (dry), 3 × 10−4 S/cm (hydrated) | 2021 |
| Polydopamine/carboxylic GO/PLLA | 0.03% wt | PNS | Surface conductivity: 17.35 S/m | 2020 | |
| PCL/G | 1% and 2% | NTE | ↑ concentration => ↑ fiber diameter, elastic modulus, max stress, and differentiation | 2019 | |
| * GO/ApF/PLCL | 1–2 mg/mL | Sciatic nerve repair, Schwann cells and PC12 | Optimum (mg/mL): 2 | 2019 | |
| G/PVA | 1% | PNS | Orientation Index: aligned scaffold: 28.7° and native nerve: 26.8°, hydrophile, strength: aligned: 29.6 ± 6.7 MPa, + ES => ↑ CPM (aligned > random) | 2018 | |
| G/Sodium alginate/PVA | (0.5–5)% wt | NTE | Optimum: 1%, ↑ concentration => ↑contact angle, degradation, conductivity (1%): 800 μs, ↑ CPM (1.4 times in 1%) | 2017 | |
| Polypyrrole/G/PLGA | 1 and 6 % PPy-G | Optical NR (Glaucoma) | Well aligned, +ES => ↑ cell length | 2016 | |
|
| * Grafted GO/PEI | Mass ratio (GO-PEI): 1:10, 1:40, and 1:70 | Recruit and stimulate the neural-like differentiation | Optimum ratio: GO-PEI 1:10, ↑ neuronal differentiation, controlled delivering the CXCL12 and GO-PEI/pDNAs-bFGF => endogenous stem cell therapy | 2021 |
| * GO/diacerein-terminated 4-armed polyethylene glycol | 2.5, 5.0, and 7.5 mg/mL | SCI | Optimum concen. (mg/mL): 5.0, Diacerein => ↓↓ inflammatory response and ↓↓, inhibitory microenvironment, conductivity (7.4 S/m) => ↑ neuron growth and axon remyelination | 2020 | |
| Polyacrylamide/GO/gelatin/sodium alginate (PAM/GO/Gel/SA) | 0.5% and 1% | PNS | Optimum %: 0.5, ↑ protein adsorption | 2018 | |
| GO acrylate (GOa) and CNTpega embedded in OPF hydrogel MTAC => rGOaCNTpega-OPF-MTAC | 0.1% | Neuronal proliferation and differentiation | Conductivity: 5.75 × 10−3 S/m | 2017 | |
| GO/polyacrylamide | (0.5–3)% | PNS | Optimum %: 0.4% GO, ↑ biofactors release and larger matrix adsorption | 2016 | |
|
| Hollow GO/gelatin | 5 mg/mL | NR and CNS | Prevent the fibroglial tissue formation | 2020 |
| GO/SA and rGO/SA | 0.5, 1, 3, and 5 mg/mL | CNS | ↑ porous and electroconductive | 2019 | |
|
| G foam/PCL mesoporous coating | 1–7.3 wt% | NTE | Conductivity and MP (Young’s modulus): | 2021 |
|
| PU/G or PU/GO | 10, 25, and 50 ppm | CNS | Optimum ppm: 25 | 2017 |
| gelatin methacrylamide (GelMA)/G | 1 mg/mL | NR | ↑ CPM | 2016 |
Studies related to the nerve guidance conduit development based on graphene-based materials. Keywords: BM-MSCs, bone marrow-derived mesenchymal stem cells; SC, stem cell; NR, nerve regeneration; CNS, central nervous system; PNS, peripheral nerve system; SCI, spinal cord injury; SDR, Sprague–Dawley rat; PNR, peripheral nerve regeneration; CPM, cell proliferation and migration; RGD, arginylglycylaspartic acid; PCL, poly(ε-caprolactone), PVDF, polyvinylidene fluoride; PLA, polylactic acid; ApF, Antheraea pernyi silk fibroin; NI, not investigated; ↓, lower or decrease, ↑, higher or enhance; =>, result in; and +, by addition.
| Biomaterial(s) | GBMs | Target and Cell Type | Animal Model | Outcomes | Year, Ref | |
|---|---|---|---|---|---|---|
|
| PLCL/GO | 1 mg/mL | PNS | SDR | Elastic modulus: 125 MPa | 2020 |
| PCL/carbon and G nanoparticles | 0.5% | PNS | Lewis rats | ↑ CPM | 2017 | |
|
| PCL/collagen/G | 0.5%, 1%, 1.5%, and 2% | Sciatic nerve repair | SDR | Well aligned | 2020 |
| Dual-electrospun: | 0–3% wt | PNS | NI | Optimum: 2% PAG => | 2020 | |
|
| G/PCL | 2% wt | PNS | NI | Elastic modulus: 2.67 MPa | 2021 |
| PVDF/GO | 0.5%, 1%, 3%, and 5% wt | PNS | NI | ↑ piezoelectricity and electrical conductivity | 2019 | |
|
| GMT/ hydrogel with netrin-1 | 0.05% | PNS | SDR | Elastic modulus: 720 kPa | 2021 |
| GO/GelMA then chemically reduced => | 0.1% | PC12 cells | SDR | Conductivity: 4.4 × 10−3 S/m (GO/GelMA) and 8.7 × 10−3 S/m (rGO/GelMA) | 2020 | |
| Chitosan/oxidized hydroxyethyl cellulose (CS/OHEC) hydrogel loaded with asiaticoside liposome and rGO | 0%, 1%, 2%, 4%, 6%, 8%, and 10% | PNS | NI | Optimum: 8% | 2020 | |
|
| Amino-functionalized G/collagen | 0.1%, 0.5%, and 1% | SCI | Organotypic spinal explant culture | Optimum %: 0.5% | 2021 |
|
| Electrospinning, molding, and freeze drying: | 2% | PNS | SDR | Effective guiding interface => ↑ CPM and ↑ myelination | 2020 |
| Aligned electrospun and film: | 0.05% | PNSPC12 and L929 fibroblasts | SDR | ↑ CPMConductivity: ~4.6 S/cm (after 4 weeks of immersion) | 2019 | |
| Molding, phase separation (conduit), and 3D printing (circuit): | Not reported | PNI | NI | + ES => | 2019 | |
| 3D printing-film: | 1% | PNS | SDR | Conductivity: 8.92 × 10−3 S/cm (SG) and 6.37 × 10−3 S/cm (MG) | 2018 | |
| Molding/jet spraying/3D printing: | 0.5%, 1%, 2%, and 4% | PNS | SDR | Optimum %: 1% | 2018 |
Figure 4(A,B) exhibiting the morphology of electrospun mats by increasing the GBMs concentration. Reused with permission from [44,45].
Figure 5The schematic illustration of ES effect on neural injury regeneration (A) Injured neuron without the conductive platform and electrical stimulation, (B) Injured neuron exposed conductive platform and electrical stimulation. Reused with permission from [6].
Figure 6(A) Mechanism of the engineered system of GO-based gene delivery that induces differentiation of recruited BMSCs for cutaneous nerve regeneration. Reused with permission from [69]. (B) Immunofluorescence images indicate the structure of the injured spinal cords and the distribution of three important marker proteins: glial fibrillary acidic protein (GFAP), microtubule-associated protein 2 (MAP-2), and neuron-specific class III β-tubulin (TUJ-1). Scale bar: 500 μm. Reused with permission from [70].
Figure 73D bioprinting structure made of PU/G. (A) Side view, (B) top view of the construct, and (C) image of neural stem cells encapsulated in the scaffold. Cells were labelled with PKH26 (red fluorescence). Reused with permission from [81].
Figure 8(A) Schematic of netrin-1-loaded GMT/hydrogel conduit preparation. (a,b) Growing G onto a nickel mesh (CVD method), (c) covering G/nickel mesh with a precursor solution, (d) formation of strong ionic bonds between alginate and Ca2+ ions due to immersing GMT into CaCl2 solution, (e,f) polymerization of GelMA under UV light, (g) etching nickel template, and (h) Immersing the conduit in high concentrated netrin-1 solution, (i) peripheral nerves regeneration. Reused with permission from [95]. (B) Images of regeneration of muscle after NGC implantation in different groups. Reused with permission from [97].
Figure 9(A) Schematic of projected collagen graphene cryogel mechanism: due to spinal cord injury, inflammatory cytokines and infiltration of inflammatory cells have been produced. By implanting the cryogels, it will promote proliferation and stemness maintenance of BM-MSCs and secrete anti-inflammatory biomolecules. Further, the presence of cryogels and macrophage infiltration will stimulate high polarization of the M2/M1 phenotype. Reused with permission from [98]. (B) The illustration depicts the PLCL film fabrication with stripe micropatterns and GO nanosheets and its use in four steps: (1) creating micropatterns by thermal pressing of a polydimethylsiloxane template onto a PLCL film, (2) aminolyzing by 1,6-hexanediamine then GO adsorption electrostatically, (3) manufacturing micropatterned PLCL/GO conduit, and (4) implanting into a rat with sciatic nerve defects. The middle schematic shows that the micropatterned PLCL/GO film can improve the directional migration of Schwann cells from their cell spheroids, induce the macrophages differentiation into M2 type, and guide the neurites of N2a cells along with the patterns. Reused with permission from [99].